Virtual CME Program
1.00 CME/CE Credit
Diabesity: A Comprehensive Approach to Managing Diabetes and Obesity
This session will delve into the intersection of obesity and type 2 diabetes. Learners will explore strategies for glycemic and weight management, cardiorenal protection, and cardiovascular risk mitigation, with an emphasis on the latest guidelines for managing type 2 diabetes and providing holistic care.
CME/CE Information
1.00 AMA PRA Category 1 Credits™, including 1.00 AAFP Prescribed Credits, 1.00 ABIM MOC or 1.00 AANP, including 0.25 AANP Pharm
Release Date: 1/30/2025
Expiration Date: 3/1/2025
Faculty
Learning Objectives
- Explore the connection between type 2 diabetes mellitus (T2DM) and obesity, and the therapeutic benefits of sustained weight loss in reducing long-term health risks
- Discuss a holistic, integrated approach to the management of T2DM, obesity, and other comorbid conditions
- Review recent guideline recommendations for T2DM management that stratify therapies based on their potential to achieve both glycemic control and weight loss
- Examine the evidence supporting the use of GLP-1 receptor agonists and SGLT2 inhibitors for cardiorenal protection in patients with T2DM and obesity
Faculty
Charles Vega, MD, FAAFP
Health Sciences Clinical Professor
Assistant Dean for Culture & Community Education
Executive Director, UC Irvine Program in Medical Education for the Latino Community UC Irvine School of Medicine
Irvine, CA
Disclosures
The following relevant financial relationships have been disclosed by faculty, and all have been mitigated by Pri-Med Institute.
Charles Vega, MD, FAAFP (Faculty): Consultant for Boehringer Ingelheim and Exact Sciences.
Non-faculty contributors and others involved in the planning, development, editing, and review of the content have disclosed no relevant financial relationships.
CME/CE Information
AMA PRA Category 1 Credits™
Accreditation Statement
Pri-Med Institute is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement
Pri-Med Institute designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAFP Prescribed Credits
Accreditation Statement
The AAFP has reviewed Updates in Cardiometabolic Health, and deemed it acceptable for AAFP credit. Term of approval is from 1/30/2025 to 1/30/2025. Physicians should claim only the credit commensurate with the extent of their participation in the activity. This session Diabesity: A Comprehensive Approach to Managing Diabetes and Obesity is approved for 1.00 Live AAFP Prescribed credit.
AANP
Accreditation Statement
Pri-Med Institute is accredited by the American Association of Nurse Practitioners® as an approved provider of nurse practitioner continuing education. Provider number: 040308.
Designation Statement
This activity is approved for 1.00 contact hour of continuing education, which includes 0.25 hours of pharmacology.
MOC Credit Information
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Medical Knowledge MOC point in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Instructions for Obtaining Credit
Fine Print
The preferred browser is Google Chrome. If using a different browser, such as Safari, Firefox or Edge, make sure you are using the most up-to-date version. Your Internet settings should be set to accept cookies and JavaScript. If cookies and/or JavaScript are disabled, the site may not function properly. A high-speed Internet connection is not required; however, it is recommended for faster download times.
The opinions, ideas, and recommendations expressed in this educational activity are those of the faculty only and are not necessarily endorsed by, nor do they necessarily reflect, those of their affiliated institutions, Pri-Med Institute, Pri-Med Institute Advisory Boards and Consultants, DBC Pri-Med, LLC.
Clinical judgment must guide each clinician in weighing the possible risks, benefits, or contraindications of any diagnostics, interventions or treatments discussed. Clinicians should review manufacturers’ product information and consider these with the recommendations of other authorities when applying the assessment and/or clinical management strategies discussed in this activity to the care of their patients.
Pri-Med Institute educational activities are developed and conducted in accordance with the ACCME's Standards for Integrity and Independence in Accredited Continuing Education. It is the mission of Pri-Med Institute to develop and present educational activities that are timely, fair-balanced, scientifically rigorous, and that serve to improve patient outcomes. To that end, we welcome your comments about how to better serve your needs.
Pri-Med Institute Accredited Provider
Pri-Med programs are owned and operated by DBC Pri-Med, LLC, a division of Diversified Communications, Inc. Pri-Med Institute, the accredited division of Pri-Med, is accredited with commendation by the ACCME and approved as a provider of continuing education by the AANP.
Disclosures and Conflict of Interest
Pri-Med Institute requires all individuals in a position to influence educational content for Pri-Med Institute-certified CME/CE activities to disclose personal financial relationships with commercial interests or ineligible companies prior to contributing to its educational activities. Pri-Med Institute assesses disclosed relationships and follows a defined process to mitigate real or implied conflicts to ensure, to the best of its ability, that all educational content is free of commercial bias. All relevant financial relationships have been mitigated Financial disclosures for everyone in control of educational content are provided before the start of each CME/CE activity.
Discussion of Off-Label Uses and Investigational Products
During the course of their presentations, the faculty may mention uses of products that have not been approved in the United States for the indication(s) being discussed. All presenters are instructed to notify participants when they are discussing unapproved uses or investigational agents. In addition, specific slides will include notation of the off-label use or investigational agent being discussed. Views presented related to unapproved uses of products are solely those of the presenter(s) and are not endorsed by Pri-Med Institute or DBC Pri-Med, LLC.
Questions?
If you have questions about this activity, please email support@pri-med.com or call (877) 477-4633.